2015 Meetings Slides and Agendas
| Topic |
Date |
Title |
Slides and Agendas |
| Novel Anticoagulants |
February 3, 2015 |
NOAC Reversal Agent Think Tank Follow-up: Post-Approval Safety and Effectiveness |
Slides & Agenda |
| Annual Meeting |
February 19, 2015 |
2015 Annual Meeting |
Slides & Agenda |
| Sudden Cardiac Death |
February 20, 2015 |
Prevention of Sudden Cardiac Death in the Young: Developing A Rational, Reliable and Sustainable National Health Care Resource |
Slides & Agenda |
| Cell Therapies for CV Indications |
October 23, 2015 |
CSRC Roundtable Discussion: Cardiovascular Safety for Cell Therapies in Development for Cardiovascular Indications |
Slides & Agenda |
| Social Listening |
November 4, 2015 |
CSRC/DIA: Social Listening and Safety Surveillance— Enabling Opportunities for Cardiac Safety |
Slides |
| Long-Term Electrocardiographic Monitoring |
December 2, 2015 |
Long Term Electrocardiographic Monitoring: Its Role in Clinical Drug Development and Population Screening |
Slides & Agenda |
| Novel Anticoagulants |
December 3, 2015 |
Is There a Role For Pharmacokinetic/Pharmacodynamics Guided Dosing For Novel Anticoagulants? |
Slides & Agenda |
